Clinical Trial Update: Study of Pyridoxine for Hand-Foot Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pyridoxine (vitamin B6) for hand-foot syndrome has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand-foot Syndrome
• Palmar-plantar Erythrodysesthesia

Drugs mentioned

• Pyridoxine (Pyridoxine)

Snippet

Sponsor: Asan Medical Center | Conditions: Hand-foot Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2014-02-25